
    
      This is a monocentric study. It's a case-control study with case being first-ever ischemic
      stroke and controls being healthy (stroke free) subject patients paired for age, sex and
      cardiovascular risk or hemorrhagic stroke paired for age and sex.

      Patients are followed for one year. Blood samples will be taken at inclusion, 12h, 24h, 48h,
      7d, 3m and 1y. Microvesicles samples will be taken at inclusion, 7d and 3M.
    
  